Share Price and Basic Stock Data
Last Updated: December 19, 2025, 7:57 pm
| PEG Ratio | 3.08 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Gillette India Ltd, a prominent player in the personal care industry, has shown a commendable trajectory in its revenue growth. For the fiscal year ending June 2023, the company reported sales of ₹2,477 Cr, up from ₹2,256 Cr in the previous year, indicating a robust growth rate of approximately 9.8%. This upward momentum is reflected in the quarterly sales figures as well, with the latest quarter ending September 2023 recording sales of ₹668 Cr, a notable increase compared to ₹619 Cr in the same quarter last year. Despite facing challenges such as inflationary pressures and competitive dynamics, Gillette’s ability to maintain a steady increase in sales underscores its strong brand equity and customer loyalty. Furthermore, the trailing twelve months (TTM) revenue stood at ₹2,942 Cr, suggesting that the company is poised for continued growth as it adapts to evolving consumer preferences and market conditions.
Profitability and Efficiency Metrics
Profitability remains a cornerstone of Gillette India’s business model, with the company boasting an impressive operating profit margin (OPM) of 30% as of the latest fiscal year. This figure is a testament to its operational efficiency and effective cost management strategies. The net profit for the same period reached ₹563 Cr, reflecting a healthy profit margin of 18.68%. Notably, Gillette’s return on equity (ROE) was reported at 41.6%, which is significantly higher than many of its peers in the personal care sector, indicating that the company is effectively utilizing shareholder funds to generate profit. The cash conversion cycle (CCC) of -17 days suggests that Gillette is efficient in managing its receivables and inventory, a critical aspect in the fast-paced consumer goods market. However, the company’s OPM has shown some fluctuations, dipping to 21% in September 2023, which may indicate potential pricing pressures or increased competition in specific product lines.
Balance Sheet Strength and Financial Ratios
Gillette India’s balance sheet appears solid, characterized by zero borrowings and reserves of ₹1,130 Cr. This financial structure provides the company with a significant buffer against economic downturns and positions it well for future investments or strategic acquisitions. The interest coverage ratio (ICR) of 75.73x further underscores its ability to meet any potential financial obligations comfortably. However, the price-to-book value (P/BV) ratio stands at a high 24.31x, which might suggest that the stock is relatively overvalued compared to its book value. Investors should be cautious, as a stretched valuation could lead to volatility if the market sentiment shifts. Moreover, Gillette’s return on capital employed (ROCE) of 56.1% is striking, indicating that it is generating substantial returns relative to its capital base, a crucial factor for long-term sustainability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Gillette India reflects a strong commitment from its promoters, who hold 75% of the company’s shares. This significant ownership stake can instill confidence among retail investors, as it suggests alignment of interests between management and shareholders. The presence of foreign institutional investors (FIIs) has been gradually increasing, standing at 5.01% as of the latest reports, which may indicate growing interest from global investors in the company’s potential. However, the declining stake of domestic institutional investors (DIIs) to 9.15% raises some questions about local institutional confidence in the stock. The number of shareholders has increased to 52,984, reflecting a growing retail interest, although this could also mean that the stock is becoming more fragmented. Such dynamics can influence stock price movements and overall market sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Gillette India faces a mixed bag of opportunities and challenges. On the one hand, its strong brand reputation, coupled with a solid financial foundation, suggests that it is well-positioned to capitalize on the growing personal care market in India. However, the company must navigate risks associated with rising raw material costs and intensifying competition, which could pressure margins. Additionally, the high valuation metrics may lead to increased scrutiny from investors, especially if growth rates begin to slow. As the market evolves, Gillette will need to innovate and possibly diversify its product offerings to stay ahead. For investors, this stock could offer stability and growth potential, but the high valuation and competitive landscape warrant a cautious approach. Keeping an eye on quarterly performance and market trends will be essential for making informed investment decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 8,790 Cr. | 270 | 334/190 | 70.6 | 38.8 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 43.5 Cr. | 25.3 | 37.0/23.3 | 85.3 | 65.2 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 119 Cr. | 125 | 149/23.4 | 32.5 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 534 Cr. | 360 | 488/204 | 60.9 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 10,317 Cr. | 281 | 423/268 | 28.2 | 55.8 | 1.25 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 68,650.71 Cr | 1,880.96 | 59.28 | 112.70 | 0.77% | 29.21% | 23.91% | 4.94 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 553 | 620 | 619 | 619 | 619 | 668 | 639 | 681 | 645 | 782 | 686 | 767 | 707 |
| Expenses | 441 | 484 | 493 | 485 | 476 | 530 | 483 | 519 | 470 | 591 | 503 | 542 | 496 |
| Operating Profit | 112 | 136 | 126 | 134 | 144 | 138 | 157 | 161 | 176 | 190 | 183 | 226 | 210 |
| OPM % | 20% | 22% | 20% | 22% | 23% | 21% | 25% | 24% | 27% | 24% | 27% | 29% | 30% |
| Other Income | 2 | 3 | 3 | 12 | 5 | 9 | 7 | 6 | 5 | 7 | 9 | 12 | 7 |
| Interest | 2 | 0 | 3 | 1 | 3 | 1 | 4 | 4 | 4 | 1 | 4 | 3 | 1 |
| Depreciation | 19 | 18 | 19 | 22 | 22 | 20 | 21 | 21 | 21 | 19 | 21 | 25 | 20 |
| Profit before tax | 92 | 120 | 106 | 123 | 124 | 125 | 139 | 143 | 155 | 177 | 167 | 210 | 195 |
| Tax % | 27% | 28% | 30% | 16% | 26% | 26% | 25% | 31% | 25% | 25% | 25% | 24% | 25% |
| Net Profit | 68 | 87 | 74 | 103 | 92 | 93 | 104 | 99 | 116 | 133 | 126 | 159 | 146 |
| EPS in Rs | 20.74 | 26.63 | 22.85 | 31.52 | 28.16 | 28.45 | 31.90 | 30.41 | 35.59 | 40.82 | 38.66 | 48.70 | 44.71 |
Last Updated: August 2, 2025, 1:15 am
Below is a detailed analysis of the quarterly data for Gillette India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 707.00 Cr.. The value appears to be declining and may need further review. It has decreased from 767.00 Cr. (Mar 2025) to 707.00 Cr., marking a decrease of 60.00 Cr..
- For Expenses, as of Jun 2025, the value is 496.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 542.00 Cr. (Mar 2025) to 496.00 Cr., marking a decrease of 46.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 210.00 Cr.. The value appears to be declining and may need further review. It has decreased from 226.00 Cr. (Mar 2025) to 210.00 Cr., marking a decrease of 16.00 Cr..
- For OPM %, as of Jun 2025, the value is 30.00%. The value appears strong and on an upward trend. It has increased from 29.00% (Mar 2025) to 30.00%, marking an increase of 1.00%.
- For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 5.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 20.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 25.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 5.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 195.00 Cr.. The value appears to be declining and may need further review. It has decreased from 210.00 Cr. (Mar 2025) to 195.00 Cr., marking a decrease of 15.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 25.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 146.00 Cr.. The value appears to be declining and may need further review. It has decreased from 159.00 Cr. (Mar 2025) to 146.00 Cr., marking a decrease of 13.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 44.71. The value appears to be declining and may need further review. It has decreased from 48.70 (Mar 2025) to 44.71, marking a decrease of 3.99.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:45 am
| Metric | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025n n 9m | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,662 | 1,875 | 1,755 | 1,733 | 1,677 | 1,862 | 1,679 | 1,982 | 2,256 | 2,477 | 2,633 | 2,235 | 2,971 |
| Expenses | 1,589 | 1,684 | 1,448 | 1,348 | 1,290 | 1,478 | 1,319 | 1,522 | 1,773 | 1,937 | 1,995 | 1,635 | 2,144 |
| Operating Profit | 73 | 191 | 306 | 385 | 387 | 384 | 360 | 460 | 483 | 540 | 638 | 600 | 826 |
| OPM % | 4% | 10% | 17% | 22% | 23% | 21% | 21% | 23% | 21% | 22% | 24% | 27% | 28% |
| Other Income | 38 | 68 | 50 | 34 | 8 | 11 | 11 | 32 | 7 | 22 | 20 | 27 | 36 |
| Interest | 0 | 5 | 6 | 7 | 7 | 8 | 5 | 5 | 11 | 8 | 13 | 9 | 13 |
| Depreciation | 33 | 39 | 30 | 38 | 42 | 48 | 51 | 58 | 68 | 81 | 83 | 64 | 85 |
| Profit before tax | 78 | 215 | 320 | 374 | 345 | 339 | 314 | 429 | 411 | 473 | 562 | 554 | 765 |
| Tax % | 34% | 26% | 33% | 32% | 34% | 25% | 27% | 28% | 30% | 25% | 27% | 25% | |
| Net Profit | 51 | 158 | 214 | 253 | 229 | 253 | 230 | 310 | 289 | 356 | 412 | 418 | 574 |
| EPS in Rs | 15.78 | 48.53 | 65.73 | 77.67 | 70.29 | 77.62 | 70.64 | 95.25 | 88.79 | 109.15 | 126.35 | 128.17 | 176.15 |
| Dividend Payout % | 95% | 31% | 60% | 211% | 33% | 57% | 69% | 125% | 78% | 78% | 103% | 87% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 4% |
| 3 Years: | 4% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 10% |
| 3 Years: | 11% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 14% |
| 3 Years: | 25% |
| 1 Year: | 17% |
| Return on Equity | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 36% |
| 3 Years: | 39% |
| Last Year: | 42% |
Last Updated: September 4, 2025, 9:25 pm
Balance Sheet
Last Updated: December 4, 2025, 12:51 am
| Month | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 |
| Reserves | 611 | 710 | 904 | 468 | 662 | 746 | 879 | 756 | 829 | 956 | 939 | 991 | 1,130 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 411 | 468 | 488 | 498 | 515 | 432 | 441 | 606 | 758 | 927 | 859 | 895 | 987 |
| Total Liabilities | 1,054 | 1,210 | 1,424 | 998 | 1,209 | 1,210 | 1,352 | 1,395 | 1,619 | 1,916 | 1,831 | 1,918 | 2,149 |
| Fixed Assets | 173 | 156 | 178 | 214 | 264 | 300 | 296 | 310 | 363 | 389 | 347 | 342 | 322 |
| CWIP | 61 | 63 | 88 | 63 | 40 | 25 | 21 | 72 | 65 | 32 | 26 | 17 | 31 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 821 | 991 | 1,158 | 721 | 904 | 886 | 1,034 | 1,013 | 1,191 | 1,494 | 1,458 | 1,558 | 1,797 |
| Total Assets | 1,054 | 1,210 | 1,424 | 998 | 1,209 | 1,210 | 1,352 | 1,395 | 1,619 | 1,916 | 1,831 | 1,918 | 2,149 |
Below is a detailed analysis of the balance sheet data for Gillette India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 33.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,130.00 Cr.. The value appears strong and on an upward trend. It has increased from 991.00 Cr. (Mar 2025) to 1,130.00 Cr., marking an increase of 139.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 987.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 895.00 Cr. (Mar 2025) to 987.00 Cr., marking an increase of 92.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,149.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,918.00 Cr. (Mar 2025) to 2,149.00 Cr., marking an increase of 231.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 322.00 Cr.. The value appears to be declining and may need further review. It has decreased from 342.00 Cr. (Mar 2025) to 322.00 Cr., marking a decrease of 20.00 Cr..
- For CWIP, as of Sep 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2025) to 31.00 Cr., marking an increase of 14.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,797.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,558.00 Cr. (Mar 2025) to 1,797.00 Cr., marking an increase of 239.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,149.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,918.00 Cr. (Mar 2025) to 2,149.00 Cr., marking an increase of 231.00 Cr..
Notably, the Reserves (1,130.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025n n 9m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 73.00 | 191.00 | 306.00 | 385.00 | 387.00 | 384.00 | 360.00 | 460.00 | 483.00 | 540.00 | 638.00 | 600.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 20 | 23 | 23 | 27 | 38 | 36 | 41 | 36 | 43 | 47 | 38 | 62 |
| Inventory Days | 104 | 87 | 104 | 103 | 105 | 104 | 136 | 152 | 130 | 127 | 131 | 181 |
| Days Payable | 116 | 116 | 137 | 150 | 173 | 126 | 138 | 169 | 193 | 209 | 212 | 260 |
| Cash Conversion Cycle | 9 | -6 | -10 | -19 | -30 | 15 | 40 | 19 | -20 | -35 | -43 | -17 |
| Working Capital Days | 27 | 49 | -10 | -17 | -18 | 15 | 35 | 14 | -0 | -4 | -7 | 13 |
| ROCE % | 12% | 35% | 39% | 54% | 60% | 48% | 38% | 51% | 51% | 52% | 59% | 56% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Multi Cap Fund | 261,119 | 0.45 | 226.77 | 231,798 | 2025-12-15 04:02:53 | 12.65% |
| ICICI Prudential Smallcap Fund | 252,882 | 2.6 | 219.62 | 218,670 | 2025-12-15 05:14:53 | 15.65% |
| Nippon India Large Cap Fund | 230,361 | 0.4 | 200.06 | 221,872 | 2025-12-15 05:14:53 | 3.83% |
| Aditya Birla Sun Life ELSS Tax Saver Fund | 207,163 | 1.15 | 179.91 | 464,089 | 2025-12-07 06:45:34 | -55.36% |
| Aditya Birla Sun Life MNC Fund | 78,341 | 1.87 | 68.04 | N/A | N/A | N/A |
| ICICI Prudential Large Cap Fund | 59,209 | 0.07 | 51.42 | N/A | N/A | N/A |
| Aditya Birla Sun Life Balanced Advantage Fund | 50,000 | 0.49 | 43.42 | N/A | N/A | N/A |
| Tata India Consumer Fund | 45,000 | 1.46 | 39.08 | N/A | N/A | N/A |
| ICICI Prudential FMCG Fund | 39,072 | 1.73 | 33.93 | N/A | N/A | N/A |
| PGIM India Flexi Cap Fund | 29,333 | 0.4 | 25.47 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 128.17 | 126.35 | 109.15 | 88.79 | 95.25 |
| Diluted EPS (Rs.) | 128.17 | 126.35 | 109.15 | 88.79 | 95.25 |
| Cash EPS (Rs.) | 147.88 | 151.68 | 133.90 | 109.75 | 112.89 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 313.93 | 298.03 | 303.42 | 264.25 | 242.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 313.93 | 298.03 | 303.42 | 264.25 | 242.10 |
| Dividend / Share (Rs.) | 112.00 | 130.00 | 85.00 | 69.00 | 119.00 |
| Revenue From Operations / Share (Rs.) | 685.74 | 807.94 | 760.06 | 692.28 | 616.58 |
| PBDIT / Share (Rs.) | 192.37 | 200.53 | 172.25 | 150.42 | 151.04 |
| PBIT / Share (Rs.) | 172.65 | 175.17 | 147.49 | 129.44 | 133.39 |
| PBT / Share (Rs.) | 170.04 | 172.52 | 145.10 | 126.21 | 131.78 |
| Net Profit / Share (Rs.) | 128.16 | 126.33 | 109.14 | 88.78 | 95.24 |
| PBDIT Margin (%) | 28.05 | 24.81 | 22.66 | 21.72 | 24.49 |
| PBIT Margin (%) | 25.17 | 21.68 | 19.40 | 18.69 | 21.63 |
| PBT Margin (%) | 24.79 | 21.35 | 19.09 | 18.23 | 21.37 |
| Net Profit Margin (%) | 18.68 | 15.63 | 14.35 | 12.82 | 15.44 |
| Return on Networth / Equity (%) | 40.82 | 42.38 | 35.96 | 33.59 | 39.33 |
| Return on Capital Employeed (%) | 49.53 | 53.26 | 43.68 | 44.66 | 50.06 |
| Return On Assets (%) | 21.77 | 22.48 | 18.56 | 17.98 | 22.24 |
| Asset Turnover Ratio (%) | 1.19 | 1.41 | 1.41 | 1.50 | 1.46 |
| Current Ratio (X) | 1.64 | 1.56 | 1.53 | 1.43 | 1.46 |
| Quick Ratio (X) | 1.06 | 1.04 | 1.03 | 0.87 | 0.76 |
| Inventory Turnover Ratio (X) | 5.26 | 6.52 | 1.73 | 1.60 | 1.48 |
| Dividend Payout Ratio (NP) (%) | 85.81 | 106.84 | 65.04 | 77.71 | 138.57 |
| Dividend Payout Ratio (CP) (%) | 74.37 | 88.98 | 53.01 | 62.85 | 116.91 |
| Earning Retention Ratio (%) | 14.19 | -6.84 | 34.96 | 22.29 | -38.57 |
| Cash Earning Retention Ratio (%) | 25.63 | 11.02 | 46.99 | 37.15 | -16.91 |
| Interest Coverage Ratio (X) | 73.67 | 75.73 | 72.25 | 46.55 | 93.76 |
| Interest Coverage Ratio (Post Tax) (X) | 50.08 | 48.71 | 46.78 | 28.48 | 60.12 |
| Enterprise Value (Cr.) | 25719.18 | 23131.91 | 16107.66 | 16033.26 | 18343.17 |
| EV / Net Operating Revenue (X) | 11.51 | 8.79 | 6.50 | 7.11 | 9.13 |
| EV / EBITDA (X) | 41.02 | 35.40 | 28.69 | 32.71 | 37.27 |
| MarketCap / Net Operating Revenue (X) | 11.70 | 8.97 | 6.69 | 7.24 | 9.21 |
| Retention Ratios (%) | 14.18 | -6.84 | 34.95 | 22.28 | -38.57 |
| Price / BV (X) | 25.55 | 24.31 | 16.75 | 18.96 | 23.46 |
| Price / Net Operating Revenue (X) | 11.70 | 8.97 | 6.69 | 7.24 | 9.21 |
| EarningsYield | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
After reviewing the key financial ratios for Gillette India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Jun 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 128.17. This value is within the healthy range. It has increased from 126.35 (Jun 24) to 128.17, marking an increase of 1.82.
- For Diluted EPS (Rs.), as of Mar 25, the value is 128.17. This value is within the healthy range. It has increased from 126.35 (Jun 24) to 128.17, marking an increase of 1.82.
- For Cash EPS (Rs.), as of Mar 25, the value is 147.88. This value is within the healthy range. It has decreased from 151.68 (Jun 24) to 147.88, marking a decrease of 3.80.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 313.93. It has increased from 298.03 (Jun 24) to 313.93, marking an increase of 15.90.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 313.93. It has increased from 298.03 (Jun 24) to 313.93, marking an increase of 15.90.
- For Dividend / Share (Rs.), as of Mar 25, the value is 112.00. This value exceeds the healthy maximum of 3. It has decreased from 130.00 (Jun 24) to 112.00, marking a decrease of 18.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 685.74. It has decreased from 807.94 (Jun 24) to 685.74, marking a decrease of 122.20.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 192.37. This value is within the healthy range. It has decreased from 200.53 (Jun 24) to 192.37, marking a decrease of 8.16.
- For PBIT / Share (Rs.), as of Mar 25, the value is 172.65. This value is within the healthy range. It has decreased from 175.17 (Jun 24) to 172.65, marking a decrease of 2.52.
- For PBT / Share (Rs.), as of Mar 25, the value is 170.04. This value is within the healthy range. It has decreased from 172.52 (Jun 24) to 170.04, marking a decrease of 2.48.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 128.16. This value is within the healthy range. It has increased from 126.33 (Jun 24) to 128.16, marking an increase of 1.83.
- For PBDIT Margin (%), as of Mar 25, the value is 28.05. This value is within the healthy range. It has increased from 24.81 (Jun 24) to 28.05, marking an increase of 3.24.
- For PBIT Margin (%), as of Mar 25, the value is 25.17. This value exceeds the healthy maximum of 20. It has increased from 21.68 (Jun 24) to 25.17, marking an increase of 3.49.
- For PBT Margin (%), as of Mar 25, the value is 24.79. This value is within the healthy range. It has increased from 21.35 (Jun 24) to 24.79, marking an increase of 3.44.
- For Net Profit Margin (%), as of Mar 25, the value is 18.68. This value exceeds the healthy maximum of 10. It has increased from 15.63 (Jun 24) to 18.68, marking an increase of 3.05.
- For Return on Networth / Equity (%), as of Mar 25, the value is 40.82. This value is within the healthy range. It has decreased from 42.38 (Jun 24) to 40.82, marking a decrease of 1.56.
- For Return on Capital Employeed (%), as of Mar 25, the value is 49.53. This value is within the healthy range. It has decreased from 53.26 (Jun 24) to 49.53, marking a decrease of 3.73.
- For Return On Assets (%), as of Mar 25, the value is 21.77. This value is within the healthy range. It has decreased from 22.48 (Jun 24) to 21.77, marking a decrease of 0.71.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.19. It has decreased from 1.41 (Jun 24) to 1.19, marking a decrease of 0.22.
- For Current Ratio (X), as of Mar 25, the value is 1.64. This value is within the healthy range. It has increased from 1.56 (Jun 24) to 1.64, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has increased from 1.04 (Jun 24) to 1.06, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.26. This value is within the healthy range. It has decreased from 6.52 (Jun 24) to 5.26, marking a decrease of 1.26.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 85.81. This value exceeds the healthy maximum of 50. It has decreased from 106.84 (Jun 24) to 85.81, marking a decrease of 21.03.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 74.37. This value exceeds the healthy maximum of 50. It has decreased from 88.98 (Jun 24) to 74.37, marking a decrease of 14.61.
- For Earning Retention Ratio (%), as of Mar 25, the value is 14.19. This value is below the healthy minimum of 40. It has increased from -6.84 (Jun 24) to 14.19, marking an increase of 21.03.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 25.63. This value is below the healthy minimum of 40. It has increased from 11.02 (Jun 24) to 25.63, marking an increase of 14.61.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 73.67. This value is within the healthy range. It has decreased from 75.73 (Jun 24) to 73.67, marking a decrease of 2.06.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 50.08. This value is within the healthy range. It has increased from 48.71 (Jun 24) to 50.08, marking an increase of 1.37.
- For Enterprise Value (Cr.), as of Mar 25, the value is 25,719.18. It has increased from 23,131.91 (Jun 24) to 25,719.18, marking an increase of 2,587.27.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 11.51. This value exceeds the healthy maximum of 3. It has increased from 8.79 (Jun 24) to 11.51, marking an increase of 2.72.
- For EV / EBITDA (X), as of Mar 25, the value is 41.02. This value exceeds the healthy maximum of 15. It has increased from 35.40 (Jun 24) to 41.02, marking an increase of 5.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 11.70. This value exceeds the healthy maximum of 3. It has increased from 8.97 (Jun 24) to 11.70, marking an increase of 2.73.
- For Retention Ratios (%), as of Mar 25, the value is 14.18. This value is below the healthy minimum of 30. It has increased from -6.84 (Jun 24) to 14.18, marking an increase of 21.02.
- For Price / BV (X), as of Mar 25, the value is 25.55. This value exceeds the healthy maximum of 3. It has increased from 24.31 (Jun 24) to 25.55, marking an increase of 1.24.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 11.70. This value exceeds the healthy maximum of 3. It has increased from 8.97 (Jun 24) to 11.70, marking an increase of 2.73.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Jun 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gillette India Ltd:
- Net Profit Margin: 18.68%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 49.53% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 40.82% (Industry Average ROE: 22.42%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 50.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.06
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 45.3 (Industry average Stock P/E: 48.16)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.68%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | P&G Plaza, Cardinal Gracias Road, Mumbai Maharashtra 400099 | investorgil.im@pg.com https://www.gillette.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Anjuly Chib Duggal | Chairperson & Independent Director |
| Mr. Kumar Venkatasubramanian | Managing Director |
| Ms. Srividya Srinivasan | Executive Director & CFO |
| Mr. Srinivas Maruthi Patnam | Executive Director |
| Mr. Pramod Agarwal | Non Executive Director |
| Mr. Sanjay Asher | Independent Director |
| Mr. C P Gurnani | Independent Director |
FAQ
What is the intrinsic value of Gillette India Ltd?
Gillette India Ltd's intrinsic value (as of 19 December 2025) is 5457.42 which is 31.65% lower the current market price of 7,984.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 26,001 Cr. market cap, FY2025-2026 high/low of 11,505/7,412, reserves of ₹1,130 Cr, and liabilities of 2,149 Cr.
What is the Market Cap of Gillette India Ltd?
The Market Cap of Gillette India Ltd is 26,001 Cr..
What is the current Stock Price of Gillette India Ltd as on 19 December 2025?
The current stock price of Gillette India Ltd as on 19 December 2025 is 7,984.
What is the High / Low of Gillette India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gillette India Ltd stocks is 11,505/7,412.
What is the Stock P/E of Gillette India Ltd?
The Stock P/E of Gillette India Ltd is 45.3.
What is the Book Value of Gillette India Ltd?
The Book Value of Gillette India Ltd is 357.
What is the Dividend Yield of Gillette India Ltd?
The Dividend Yield of Gillette India Ltd is 1.40 %.
What is the ROCE of Gillette India Ltd?
The ROCE of Gillette India Ltd is 56.1 %.
What is the ROE of Gillette India Ltd?
The ROE of Gillette India Ltd is 41.6 %.
What is the Face Value of Gillette India Ltd?
The Face Value of Gillette India Ltd is 10.0.